StockData
Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc. (HRTX) stock

HRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$0.27−0.01 (-3.26%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Heron Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Heron Therapeutics's price to book ratio was 9.6× on Nov 11, 2026, against 13.1× a year earlier. Over the last 5 years it ranged from 2.6× to 21.0×, with a median of 6.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.6×−5.1
2025Dec 31, 202514.7×−6.3
2023Apr 28, 202321.0×+15.0
2022Apr 29, 20225.9×−1.4
2021Dec 31, 20217.4×+0.5
2020Dec 31, 20206.9×+0.4
2019Dec 31, 20196.5×+2.2
2018Dec 31, 20184.3×−18.0
2017Dec 29, 201722.3×−4.8
2016Dec 30, 201627.2×+21.3
2015Dec 31, 20155.9×+2.9
2014Dec 31, 20143.0×−3.6
2013Dec 31, 20136.6×+1.2
2012Apr 30, 20125.3×−5.6
2011Jul 29, 201111.0×–

More Heron Therapeutics figures

See a number that looks wrong?